Clinical Response to Immune Checkpoint Inhibitors Is Associated With Response to Prior Platinum-based Chemotherapy in Non-small Cell Lung Cancer With Low or Negative Programmed Death Ligand-1 Expression
A79. DEFINING LUNG CANCER DEVELOPMENT AND CHARACTERISTICS（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined